NHS rejects 'life-changing' breakthrough migraine drug after a row about how effective it is 

Officials will announce today that breakthrough migraine drug erenumab will not be available on the NHS due to a row over clinical evidence, despite patients praising its life-changing effects.

Source: the Mail online | Health - September 26, 2019 Category: Consumer Health News Source Type: news